EUVIMEDEUVIMED entdecken
Crossref

Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2 / NF‐κB pathway

Jingfei Fu iD, Lu Jia, Lili Wu, Yiyang Jiang iD, Rui Zhao, Juan Du, Lijia Guo, Chen Zhang, Junji Xu, Yi Liu iD

Oral Diseases · 2024

DOI: 10.1111/odi.14712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Jingfei Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruc…. Hauptthemen laut MEDLINE: Osteoclasts, Lacticaseibacillus rhamnosus, Cell Differentiation, Toll-Like Receptor 2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: the Innovation Research Team Project of Beijing Stomatological Hospital, Capital Medical University, Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, Beijing Municipal Administration of Hospitals' Ascent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to investigate the role of ultrasonicated Lactobacillus rhamnosus extract in osteoclast differentiation and its underlying mechanism, providing new strategies for the treatment of periodontitis. Materials and Methods Osteoclasts were induced using macrophage colony‐stimulating factor and receptor activator for nuclear factor‐κB ligand. Lactobacillus rhamnosus extracts were obtained via ultrasonic crushing and ultracentrifugation. The effects of the LGG extract on osteoclast differentiation were evaluated, and the related signaling pathways were examined using western blotting. A mouse periodontitis model was established, and Lactobacillus rhamnosus extract was injected into the gingival sulcus to evaluate the inhibitory effect of Lactobacillus rhamnosus extract on alveolar bone resorption.

Results

At 50 μg/mL, Lactobacillus rhamnosus extract inhibited osteoclast differentiation with no effect on apoptosis and proliferation. This phenomenon was achieved by deactivating the NF‐κB/c‐Fos/NFATc1 signaling pathway through toll‐like receptor 2. The in vivo results showed that the local injection of Lactobacillus rhamnosus extract suppressed osteoclast differentiation and alveolar bone resorption.

Conclusion

The ultrasonicated extract of Lactobacillus rhamnosus inhibited osteoclast differentiation by suppressing the activation of the NF‐κB/c‐Fos/NFATc1 pathway. Furthermore, it inhibited the destruction of the alveolar bone, providing a new strategy for the use of probiotics in the treatment of periodontitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsLacticaseibacillus rhamnosusCell DifferentiationToll-Like Receptor 2NF-kappa BSignal TransductionPeriodontitisAnimalsMiceNFATC Transcription FactorsAlveolar Bone LossProto-Oncogene Proteins c-fosProbioticsDisease Models, AnimalMale

Stichwörter der Autor:innen

Lactobacillus rhamnosusNF‐κBosteoclastperiodontitistoll‐like receptor 2

Substanzen

Toll-Like Receptor 2NF-kappa BTlr2 protein, mouseNFATC Transcription FactorsNfatc1 protein, mouseProto-Oncogene Proteins c-fos

Autor:innen und Institutionen

  • Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, Chin…
  • Department of Orthodontics School of Stomatology, Capital Medical University, Beijing, China.
  • Department of Neurobiology, School of Basic Medical Sciences, Beijing Key Laboratory of Neural Regeneration and Repair, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.

ORCID-Profile: Jingfei Fu, Yiyang Jiang, Yi Liu

Förderung

  • the Innovation Research Team Project of Beijing Stomatological Hospital, Capital Medical University
  • Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
  • Beijing Municipal Administration of Hospitals' Ascent Plan
  • Beijing Municipal Administration of Hospitals' Youth Programme
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Fu, J., Jia, L., Wu, L., Jiang, Y., Zhao, R., Du, J., Guo, L., Zhang, C., Xu, J., & Liu, Y. (2024). Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2 / NF‐κB pathway. Oral Diseases. https://doi.org/10.1111/odi.14712

Vancouver

Fu J, Jia L, Wu L, Jiang Y, Zhao R, Du J, et al. Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2 / NF‐κB pathway. Oral Diseases. 2024. doi:10.1111/odi.14712

BibTeX
@article{Fu2024,
  author = {Fu, Jingfei and Jia, Lu and Wu, Lili and Jiang, Yiyang and Zhao, Rui and Du, Juan and Guo, Lijia and Zhang, Chen and Xu, Junji and Liu, Yi},
  title = {Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2 / NF‐κB pathway},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14712}
}
Kostenlos starten →